Draft Website - For Review Purposes Only

The RXE segment details the pharmacy or treatment application's encoding of the order. It also contains several pharmacy-specific order status fields, such as RXE-16-number of refills remaining, RXE-17-number of refills/doses dispensed, RXE-18-D/T of most recent refill or dose dispensed, and RXE-19-total daily dose.

Note that ORC-7-quantity/timing has a different meaning from RXE-1-quantity/timing and RXG-3-quantity/timing. The pharmacy or treatment department has the "authority" (and/or necessity) to schedule dispense/give events. Hence, the pharmacy or treatment department has the responsibility to encode this scheduling information in RXE-1-quantity/timing and RXG-3-quantity/timing. ORC-7-quantity/timing does not change: it always specifies the requested give/dispense schedule of the original order.

HL7 Attribute Table - RXE - Pharmacy/Treatment Encoded Order Segment

Seq#	DataElement	Description	Must Implement	Flags	Cardinality	Length	C.LEN	Vocabulary	DataType
RXE
1	00221	Quantity/Timing	SHALL NOT	W	[0..0]
2	00317	Give Code	SHALL		[1..1]			0292 Vaccines Administered	CWE
3	00318	Give Amount - Minimum	SHALL		[1..1]				NM
4	00319	Give Amount - Maximum			[0..1]				NM
5	00320	Give Units	SHALL		[1..1]			0715	CWE
6	00321	Give Dosage Form			[0..1]			0716	CWE
7	00298	Provider's Administration Instructions			[0..*]			0752	CWE
8	00299	Deliver-To Location	SHALL NOT	W	[0..0]
9	00322	Substitution Status			[0..1]	[1..1]		0167 Substitution Status	ID
10	00323	Dispense Amount	MAY True: False:	C	[1..1] [0..1]				NM
11	00324	Dispense Units	MAY True: False:	C	[1..1] [0..1]			0720	CWE
12	00304	Number Of Refills		=	[0..1]		3		NM
13	00305	Ordering Provider's DEA Number		B	[0..*]				XCN
14	00306	Pharmacist/Treatment Supplier's Verifier ID		B	[0..*]				XCN
15	00325	Prescription Number	MAY True: False:	C=	[1..1] [0..1]		20		ST
16	00326	Number of Refills Remaining	MAY True: False:	C	[1..1] [0..1]				NM
17	00327	Number of Refills/Doses Dispensed	MAY True: False:	C	[1..1] [0..1]				NM
18	00328	D/T of Most Recent Refill or Dose Dispensed	MAY True: False:	C	[1..1] [0..1]				DTM
19	00329	Total Daily Dose	MAY True: False:	C	[1..1] [0..1]				CQ
20	00307	Needs Human Review			[0..1]	[1..1]		0136 Yes/no Indicator	ID
21	00330	Special Dispensing Instructions			[0..*]			0721	CWE
22	00331	Give Per	MAY True: False:	C=	[1..1] [0..1]		20		ST
23	00332	Give Rate Amount		=	[0..1]		6		ST
24	00333	Give Rate Units			[0..1]			0722	CWE
25	01126	Give Strength			[0..1]				NM
26	01127	Give Strength Units			[0..1]			0723	CWE
27	01128	Give Indication			[0..*]			0724	CWE
28	01220	Dispense Package Size			[0..1]				NM
29	01221	Dispense Package Size Unit			[0..1]			0726	CWE
30	01222	Dispense Package Method			[0..1]	[1..2]		0321 Dispense Method	ID
31	01476	Supplementary Code			[0..*]			0762	CWE
32	01673	Original Order Date/Time			[0..1]				DTM
33	01674	Give Drug Strength Volume		#	[0..1]		5		NM
34	01675	Give Drug Strength Volume Units			[0..1]			0729	CWE
35	01676	Controlled Substance Schedule			[0..1]			0477 Controlled Substance Schedule	CWE
36	01677	Formulary Status			[0..1]	[1..1]		0478 Formulary Status	ID
37	01678	Pharmaceutical Substance Alternative			[0..*]			0730	CWE
38	01679	Pharmacy of Most Recent Fill			[0..1]			0732	CWE
39	01680	Initial Dispense Amount			[0..1]				NM
40	01681	Dispensing Pharmacy		B	[0..1]			0765	CWE
41	01682	Dispensing Pharmacy Address		B	[0..1]				XAD
42	01683	Deliver-to Patient Location			[0..1]				PL
43	01684	Deliver-to Address			[0..1]				XAD
44	01685	Pharmacy Order Type			[0..1]	[1..1]		0480 Pharmacy Order Types	ID
45	02310	Pharmacy Phone Number			[0..*]				XTN

(Definition from ORC.7 in Ch. 4)

Attention: The ORC-7 field was retained for backward compatibility only as of v 2.5 and the detail was withdrawn and removed from the standard as of v 2.7. The reader is referred to the TQ1 and TQ2 segments described in sections 4.5.4 and 4.5.5, respectively.

(Definition from OBR.27 in Ch. 4)

Attention: The OBR-27 element was retained for backward compatibility only as of v 2.5 and the detail was withdrawn and removed from the standard as of v 2.7.

(Definition from RXE.1 in Ch. 4A)

Attention: The RXE-1 field was retained for backward compatibilty only as of v 2.5 and the detail was withdrawn and removed from the standard as of v 2.7.

(Definition from RXG.3 in Ch. 4A)

Attention: The RXG-3 field was retained for backward compatibilty only as of v 2.5 and the detail was withdrawn and removed from the standard as of v 2.7.

(Definition from OBR.27 in Ch. 7)

Attention: The OBR-27 element was retained for backward compatibility only as of v 2.5 and the detail was withdrawn and removed from the standard as of v 2.7.

(Definition from RXE.2 in Ch. 4A)

Definition: This field identifies the medical substance or treatment that has been ordered to be given to the patient, as encoded by the pharmacy or treatment supplier; it is equivalent to OBR-4-universal service ID in function. In the RXE segment, this give code must be fully encoded. The dispense fields, which define the units and amount of what is to be issued to the patient (see RXE-10-dispense amount and RXE-11-dispense units below) do not necessarily correlate with the instructions of what amount is to be "given" or administered with each dose, and may or may not be specified with the order. For example, the "give" part of the order may convey the field-representation of give 250 mg of Ampicillin, while the request to dispense part of the order may convey issue 30 tablets of generic equivalent for this outpatient prescription.

The coding system used is conditional on both the nature of the medical substance or treatment ordered and site-specific implementation considerations. For vaccines, HL7 Table 0292 – Vaccines Administered is the preferred coding system. For non-vaccine products, the coding system may be a local implementation of User-defined Table 0479 – Pharmaceutical Substances or an external coding system. Examples of external coding systems include, but are not limited to, National Drug Codes (NDC), Medispan Generic Product Identifier (MGPI), Drug Descriptor Identifier (DDID), and other drug codes listed in HL7 Table 0396 – Coding Systems. The following examples illustrate some code tables other than User-defined Table 0479:

NDC:                0006915404^Norvasc 10mg Tabs^NDC

DDID:                015189^Norvasc 10mg Tabs^DDID

CVX (HL70292):            30^HBIG^CVX

(Definition from RXG.4 in Ch. 4A)

Definition: This field is the identifier of the medical substance/treatment ordered to be given to the patient; it is equivalent to OBR-4-Universal service ID in function. See the RXE segment for a complete definition of the RXE-2-Give code. If the substance given is a vaccine, CVX codes may be used to code this field (see HL7 Table 0292 - Vaccines administered in Chapter 2C, Code Tables).

(Definition from RXE.3 in Ch. 4A)

Definition: This field contains the ordered amount as encoded by the pharmacy or treatment supplier. In a variable dose order, this is the minimum ordered amount. In a non-varying dose order, this is the exact amount of the order.

(Definition from RXG.5 in Ch. 4A)

Definition: This field contains the ordered amount as encoded by the pharmacy/treatment supplier. In a variable dose order, this is the minimum ordered amount. In a non-varying dose order, this is the exact amount of the order.

(Definition from RXE.4 in Ch. 4A)

Definition: In a variable dose order, this is the maximum ordered amount. In a non-varying dose, this field is not used.

(Definition from RXG.6 in Ch. 4A)

Definition: In a variable dose order, this is the maximum ordered amount. In a non-varying dose order, this field is not used.

(Definition from RXE.5 in Ch. 4A)

Definition: This field contains the units for the give amount as encoded by the pharmacy or treatment (e.g., respiratory therapy) application. Refer to Table 0715 - Give Units in Chapter 2C for valid values.

A table of standard units that contains compound units is needed. Until such a table is agreed on, a user-defined table is needed for each site.

(Definition from RXG.7 in Ch. 4A)

Definition: This field contains the units for the give amount. Refer to Table 0735 - Give Units in Chapter 2C for valid values.

A table of standard units that contains compound units is needed. Until such a table is agreed on, a user-defined table is needed for each site.

(Definition from RXE.6 in Ch. 4A)

Definition: The dosage form indicates the manner in which the medication or treatment is aggregated for dispensing, e.g., tablets, capsules, suppositories. In some cases, this information is implied by the give code in RXE-2-Give Code. Use the RXE-6-Give Dosage Form when the give code does not specify the dosage form. Refer to Table 0716 - Give Dosage Form in Chapter 2C for valid values.

(Definition from RXG.8 in Ch. 4A)

Definition: The dosage form indicates the manner in which the medication/treatment is aggregated for dispensing, e.g., tablets, capsules, suppositories. In some cases, this information is implied by the give code in RXG-4-Give Code. Use this field when the give code does not specify the dosage form. Refer to Table 0736 - Give Dosage Form in Chapter 2C for valid values.

(Definition from RXO.7 in Ch. 4A)

Definition: This field identifies the ordering provider's instructions to the patient or to the provider administering the drug or treatment. If coded, a user-defined table must be used. If transmitted as free text, place a null in the first component and the text in the second, e.g., |^this is a free text administration instruction|.Refer to Table 0752 - Provider's Administration Instructions in Chapter 2C for valid values.

(Definition from RXE.7 in Ch. 4A)

Definition: This field contains the ordering provider's instructions to the patient or the provider administering the drug or treatment. If coded, a user-defined table must be used; if free text (describing a custom IV, mixture, or salve, for example), place the text in the second component, e.g., |^this is a free text administration instruction|.Refer to Table 0718 - Provider's Administration Instructions in Chapter 2C for valid values.

(Definition from RXO.8 in Ch. 4A)

Attention: The RXO-8 field was retained for backward compatibilty only as of v 2.6 and the detail was withdrawn and removed from the standard as of v 2.8.

(Definition from RXE.8 in Ch. 4A)

Attention: The RXE-8 field was retained for backward compatibilty only as of v 2.5 and the detail was withdrawn and removed from the standard as of v 2.7.

(Definition from RXE.9 in Ch. 4A)

Definition: Refer to HL7 Table 0167 - Substitution Status in Chapter 2C, Code Tables, for valid values. If a substitution has been made, and a record of the original requested give code (RXO-1-requested give code) is needed, the optional RXO segment can be included in the RDE message.

(Definition from RXD.11 in Ch. 4A)

Definition: Refer to HL7 Table 0167 - Substitution Status in Chapter 2C, Code Tables, for suggested values.

(Definition from RXG.10 in Ch. 4A)

Definition: Refer to HL7 Table 0167 - Substitution Status in Chapter 2C, Code Tables, for valid values.

Definition: This field contains the amount to be dispensed as encoded by the pharmacy or treatment supplier.

Definition: This field contains the units for the dispense amount as encoded by the pharmacy or treatment supplier. This field is required if the units are not implied by the actual dispense code. This must be in simple units that reflect the actual quantity of the substance dispensed. It does not include compound units. Refer to Table 0720 - Dispense Units in Chapter 2C for valid values.

(Definition from RXO.13 in Ch. 4A)

Definition: This field defines the number of times the requested dispense amount can be given to the patient, subject to local regulation. Refers to outpatient only.

(Definition from RXE.12 in Ch. 4A)

Definition: This field contains the total original number of refills. Outpatient only.

(Definition from RXO.14 in Ch. 4A)

Attention: This field was retained for backward compatibilty only as of v 2.7 and the detail was withdrawn and removed from the standard as of v 2.9. The reader is referred to the PRT segment described in Chapter 7.

(Definition from RXE.13 in Ch. 4A)

Definition: This field is retained for backward compatibility only as of v 27. The reader is referred to the PRT segment described in Chapter 7.

This field is defined as conditional because it is required when the substance requested is a controlled substance (e.g., a narcotic). If the person referenced in this field is also referenced in PRT segment, they must contain the same information. However, if there is a difference, then PRT segment takes precedence.

(Definition from RXO.15 in Ch. 4A)

Definition: This field is the provider ID of the pharmacist/treatment supplier verifier. Use if required by the pharmacy or treatment application or site on orders (or some subgroup of orders), in addition to ORC-11-verified by.

Example:    

The site requires a "verified by" provider (such as a nurse) and a "verifying pharmacist/treatment supplier" on the order. In this case the first field, ORC-11-verified by, is already present; but the second field, RXO-15-pharmacist/treatment supplier's verifier ID, is needed.

(Definition from RXE.14 in Ch. 4A)

Definition: This field is retained for backward compatibility only as of v 27. The reader is referred to the PRT segment described in chapter 7.

This field contains the provider ID of Pharmacist/treatment supplier's verifier. Use if required by the pharmacy or treatment application or site on orders (or some subgroup of orders). If the person referenced in this field is also referenced in PRT segment, they must contain the same information. However, if there is a difference, then PRT segment takes precedence.

(Definition from RXE.15 in Ch. 4A)

Definition: This field contains the prescription number as assigned by the pharmacy or treatment application. Equivalent in uniqueness to the pharmacy/treatment filler order number. At some sites, this may be the pharmacy or treatment system (internal) sequential form. At other sites, this may be an external form. This is a required field in RXE when used in pharmacy/treatment messages, but it is not required when used in product experience messages (see Chapter 7).

(Definition from RXD.7 in Ch. 4A)

Definition: This field is equivalent in uniqueness to the pharmacy/treatment supplier filler order number. At some sites, this may be the pharmacy/treatment supplier (internal) sequential form. At other sites, this may be an external number.

(Definition from FT1.42 in Ch. 6)

Definition: This field contains the prescription number as assigned by the pharmacy or treatment application. Equivalent in uniqueness to the pharmacy/treatment filler order number. At some sites, this may be the pharmacy or treatment system (internal) sequential form. At other sites, this may be an external form.

(Definition from RXE.16 in Ch. 4A)

Definition: Number of refills remaining. This field is conditional because it is required when a prescription is dispensed to an outpatient. It is not relevant to inpatient treatment orders.

(Definition from RXD.8 in Ch. 4A)

Definition: This field is conditional because it is required when a prescription is dispensed to an outpatient. It is not relevant to inpatient treatment orders.

Definition: Number of refills remaining. This field is conditional because it is required when a prescription is dispensed to an outpatient. It is not relevant to inpatient treatment orders.

Definition: Date/time of the most recent refill or dose dispensed.

(Definition from RXO.23 in Ch. 4A)

Definition: This field contains the total daily dose for this particular pharmaceutical as expressed in terms of actual dispense units.

(Definition from RXE.19 in Ch. 4A)

Definition: This field contains the total daily dose for this particular pharmaceutical as expressed in terms of actual dispense units.

(Definition from RXD.12 in Ch. 4A)

Definition: This field contains the total daily dose being dispensed as expressed in terms of the actual dispense units.

(Definition from RXO.16 in Ch. 4A)

Definition: This field uses HL7 Table 0136 - Yes/No Indicator in Chapter 2C, Code Tables. The values have the following meaning for this field:

Y    Yes - Indicates that the pharmacist or non-pharmacist treatment supplier filling the order needs to pay special attention to the text in the RXO-6-provider's pharmacy/treatment instructions. A warning is present.

N    No - No warning is present. This is the equivalent default (null) value.

An example of the use of this field is given by the following case:

A smart Order Entry application knows of a possible drug or treatment interaction on a certain order, but the provider issuing the order wants to override the condition. In this case, the pharmacy or treatment application receiving the order will want to have a staff pharmacist or non-pharmacist treatment supplier review the interaction and contact the ordering physician.

(Definition from RXE.20 in Ch. 4A)

Definition: This field uses HL7 Table 0136 - Yes/No Indicator in Chapter 2C, Code Tables. The values have the following meaning for this field:

Y    Yes - Indicates that a warning is present. The application receiving the encoded order needs to warn the person administering the drug or treatment to pay attention to the text in RXE-21-pharmacy/treatment special dispensing instructions.

N    No - Indicates no warning is present. This is the equivalent default (null) value.

(Definition from RXD.14 in Ch. 4A)

Definition: Refer to HL7 Table 0136 - Yes/no indicator for valid values. The values have the following meaning for this field:

Y    Yes - Indicates that a warning is present. The application receiving the dispense order needs to warn the person dispensing/administering the drug or treatment to pay attention to the text in RXD-15-Special dispensing instructions.

N    No - Indicates no warning is present. This is the equivalent default (null) value.

(Definition from RXG.12 in Ch. 4A)

Definition: Refer to HL7 Table 0136 - Yes/No Indicator for valid values. The values have the following meaning for this field:

Y    Yes - Indicates that a warning is present. The application receiving the dispense order needs to warn the person dispensing/administering the drug or treatment to pay attention to the text in RXG-13-Special administration instructions.

N    No - Indicates no warning is present. This is the equivalent default (null) value.

(Definition from RXE.21 in Ch. 4A)

Definition: This field contains the pharmacy or treatment supplier's provider-generated special instructions to the provider dispensing/administering the order. Refer to Table 0721 - Special Dispensing Instructions in Chapter 2C for valid values.

(Definition from RXD.15 in Ch. 4A)

Definition: This field contains pharmacy or treatment supplier-generated special instructions to the provider dispensing/administering the order. Refer to Table 0706 - Special Dispensing Instructions in Chapter 2C for valid values.

(Definition from RXE.22 in Ch. 4A)

Definition: This field contains the time unit to use to calculate the rate at which the pharmaceutical is to be administered.

Format:

This is the same as the format specified for the DURATION component of the quantity/timing field, excluding the "X" specification.

This field is defined as conditional because it is required when the ordered substance is to be administered continuously at a prescribed rate (e.g., certain IVs). For example, if the "give amount/units" were 300 ml and the "give per" time unit were H1 (equivalent to one hour), the rate is 300ml/hr.

(Definition from RXG.14 in Ch. 4A)

Definition: This field contains the time unit to use to calculate the rate at which the pharmaceutical/treatment is to be administered.

Format:

This is the same as the format specified for the DURATION component of the quantity/timing field, excluding the "X" specification.

Required when relevant (e.g., certain IVs). For example, if the "give amount/units" were 300 ml and the "give per" time unit were H1 (equivalent to one hour), the rate is 300ml/hr.

(Definition from RXE.23 in Ch. 4A)

Definition: This field contains the rate at which the substance should be administered.

(Definition from RXG.15 in Ch. 4A)

Definition: This field contains the amount (number) of substance/treatment to be administered.

(Definition from RXE.24 in Ch. 4A)

Definition: This field contains the units for RXE-23-give rate amount. May be composite. The ratio of the RXE-23-give rate amount and RXE-24-give rate units defines the actual rate of administration. Thus, if RXE-23-give rate amount = 100 and RXE-24-give rate units = ml/hr, the requested rate of administration is 100 ml/hr. (See ISO+ figure 7-9 in Chapter 7 for possible compound units codes.) Refer to Table 0722 - Give Rate Units in Chapter 2C for valid values.

(Definition from RXG.16 in Ch. 4A)

Definition: This field contains the units for RXG-15-give rate amount. May be composite. The ratio of the RXG-15-give rate amount and RXG-16-give rate units fields define the actual rate of administration. Thus, if RXG-15-give rate amount = 100 and RXG-16-give rate units = ml/hr, the requested rate of administration is 100 ml/hr. Refer to Table 0740 - Give Rate Units in Chapter 2C for valid values.

(Definition from RXE.25 in Ch. 4A)

Definition: Use when RXE-2-give code does not specify the strength. This is the numeric part of the strength, used in combination with RXE-26-give strength units.

(Definition from RXG.17 in Ch. 4A)

Definition: Use when RXG-4-Give code does not specify the strength. This is the numeric part of the strength, used in combination with RXG-18-Give strength units.

(Definition from RXE.26 in Ch. 4A)

Definition: Use when RXE-2-Give Code does not specify the strength. This is the unit of the strength, used in combination with RXE-25-Give Strength. Refer to Table 0723 - Give Strength Units in Chapter 2C for valid values.

(Definition from RXG.18 in Ch. 4A)

Definition: Use when RXG-4-Give Code does not specify the strength. This is the unit of the strength, used in combination with RXG-17-Give Strength. Refer to Table 0741 - Give Strength Units in Chapter 2C for valid values.

Definition: This field identifies the condition or problem for which the drug/treatment was prescribed. May repeat if multiple indications are relevant. Refer to Table 0724 - Give Indication in Chapter 2C for valid values.

(Definition from RXE.28 in Ch. 4A)

Definition: This field contains the size of package to be dispensed. Units are transmitted in RXE-29-dispense package size unit.

(Definition from RXD.22 in Ch. 4A)

Definition: This field contains the size of package to be dispensed. Units are transmitted in RXD-23-dispense package size unit.

(Definition from RXE.29 in Ch. 4A)

Definition: This field contains the units in which RXE-28-dispense package size is denominated. Refer to Table 0726 - Dispense Package Size Unit in Chapter 2C for valid values.

(Definition from RXD.23 in Ch. 4A)

Definition: This field contains the units in which RXE-28-dispense package size is denominated. The advertised number of units in the manufacturer's package, i.e., the package as it comes from the supplier. Refer to Table 0709 - Dispense Package Size Unit in Chapter 2C for valid values.

(Definition from RXE.30 in Ch. 4A)

Definition: This field contains the method by which treatment is dispensed. Refer to HL7 Table 0321 - Dispense Method in Chapter 2C, Code Tables, for valid values.

(Definition from RXD.24 in Ch. 4A)

Definition: This field contains the method by which treatment is dispensed. Refer To HL7 Table 0321 - Dispense Method in Chapter 2C, Code Tables, for valid values.

(Definition from RXO.24 in Ch. 4A)

This field accommodates the identification of any codes that might be associated with the pharmaceutical substance. Common codes include: the Generic Product Identifier (GPI), Generic Code Number_Sequence Number (GCN_SEQNO), National Drug Code (NDC). Refer to Table 0762 - Supplementary Code in Chapter 2C for valid values.

(Definition from RXC.7 in Ch. 4A)

Definition: This field accommodates the identification of any codes that might be associated with the pharmaceutical or other treatment substance. Common codes include: the Generic Product Identifier (GPI), Generic Code Number_Sequence Number (GCN_SEQNO), National Drug Code (NDC). Refer to Table 0700 - Supplementary Code in Chapter 2C for valid values.

(Definition from RXE.31 in Ch. 4A)

Definition: This field accommodates the identification of any codes that might be associated with the pharmaceutical substance. Common codes include: the Generic Product Identifier (GPI), Generic Code Number_Sequence Number (GCN_SEQNO), National Drug Code (NDC). Refer to Table 0727 - Supplementary Code in Chapter 2C for valid values.

(Definition from RXD.25 in Ch. 4A)

Definition: This field accommodates the identification of any codes that might be associated with the pharmaceutical substance. Common codes include: the Generic Product Identifier (GPI), Generic Code Number_Sequence Number (GCN_SEQNO), National Drug Code (NDC). Refer to Table 0710 - Supplementary Code in Chapter 2C for valid values.

Definition: This field contains the date/time of the original order (ORC-9) when a refill authorization is being requested. This was represented in the ORC-9 of the original order transaction.

Description: This numeric field defines the volume measurement in which the drug strength concentration is contained. For example, Acetaminophen 120 MG/5ML Elixir means that 120 MG of the drug is in a solution with a volume of 5 ML, which would be encoded in RXE-25, RXE-26, RXE-33 and RXE-34 as:

RXE|||||||||||||||||||||||||120|mg^^ISO|||||||5|ml^^ISO ...<cr>

Description: This field indicates the volumetric unit associated with RXE-33 Give Drug Strength Volume. See example in RXE-33. Refer to Table 0729 - Give Drug Strength Volume Units in Chapter 2C for valid values.

Definition: This field specifies the class of the drug or other substance if its usage is controlled by legislation. In the USA, such legislation includes the federal Controlled Substance Act (CSA) or a State Uniform Controlled Substance Act. Refer to User-defined table 0477 – Controlled Substance Schedule in Chapter 2C, Code Tables, for valid values for USA usage. Other countries should create their own versions of this table.

Because some jurisdictions may extend the list of drugs in a particular class and may create an additional schedule, table 0477 is user-defined.

Definition: This field specifies whether or not the pharmaceutical substance is part of the local formulary. Refer to HL7 table 0478 - Formulary Status in Chapter 2C, Code Tables, for valid values.

Definition: This field specifies a pharmaceutical substance that is in the formulary that could be prescribed in lieu of the substance being prescribed. In the case where the specified medication is non-formulary this field would contain therapeutic alternatives that are on the formulary. Refer to Table 0730 - Pharmaceutical Substance Alternative in Chapter 2C for valid values.

Definition: This field specifies the pharmacy that last filled the prescription. Refer to Table 0732 - Pharmacy of Most Recent Fill in Chapter 2C for valid values.

Definition: This field specifies the quantity dispensed on the original fill (first fill) of a prescription when that amount is not the same as the quantity to be used in refills. One use case is when a new medication is being prescribed and the prescriber wants to determine if the patient will tolerate the medication. The prescriber indicates that the medication should be filled for an initial amount of 30 tablets and, if tolerated, refilled using a quantity of 100 tablets. In this case, RXE-39 would contain 30 and RXE-10 would contain 100.

If this field is not populated, then the initial dispense amount is the same as RXE-10.

The units are identified in RXE-11.

(Definition from RXO.32 in Ch. 4A)

Attention: This field was retained for backward compatibilty only as of v 2.7 and the detail was withdrawn and removed from the standard as of v 2.9. The reader is referred to the PRT segment described in Chapter 7. Refer to Table 0765 - Dispensing Pharmacy in Chapter 2C for valid values.

ense the prescription.

(Definition from RXE.40 in Ch. 4A)

Definition: This field is retained for backward compatibility only as of v 27. The information formerly communicated using this field should now be communicated using the PRT segment. The reader is referred to chapter 7 for a description of that segment. Refer to Table 0733 - Dispensing Pharmacy in Chapter 2C for valid values.

This field specifies the pharmacy that will dispense or has dispensed the prescription. In the context of an order/request (i.e., in an RXO segment) this field represents the requested dispensing pharmacy. In the context of a registered order (i.e., in an RXE segment) this field represents the intended dispensing pharmacy, the pharmacy that is expected to dispense the prescription.

(Definition from RXO.33 in Ch. 4A)

Attention: This field was retained for backward compatibilty only as of v 2.7 and the detail was withdrawn and removed from the standard as of v 2.9. The reader is referred to the PRT segment described in Chapter 7.

(Definition from RXE.41 in Ch. 4A)

Definition: This field is retained for backward compatibility only as of v 27. The information formerly communicated using this field should now be communicated using the PRT segment. The reader is referred to chapter 7 for a description of that segment.

This field specifies the address of the dispensing facility.

(Definition from RXO.34 in Ch. 4A)

Definition: This field specifies the location of the patient to whom the pharmaceutical substance is to be delivered.

(Definition from RXE.42 in Ch. 4A)

Definition: This field specifies the location of the patient to whom the pharmaceutical substance is to be delivered.

(Definition from RXG.29 in Ch. 4A)

Definition: This field specifies the location of the patient to whom the pharmaceutical substance is to be delivered.

(Definition from RXO.35 in Ch. 4A)

Definition: This field specifies the address, either mailing or physical, to which the prescription should be mailed or delivered.

(Definition from RXE.43 in Ch. 4A)

Definition: This field specifies the address, either mailing or physical, to which the prescription should be mailed or delivered.

(Definition from RXG.30 in Ch. 4A)

Definition: This field specifies the address, either mailing or physical, to which the prescription should be mailed or delivered.

Definition: The Pharmacy Order Type field defines the general category of pharmacy order which may be used to determine the processing path the order will take. Refer to HL7 Table 0480 Pharmacy Order Types in Chapter 2C, Code Tables, for valid values.

This field may also be used for grouping of related orders for processing and/or reports. For example, Medication Administration Records (MARs) often group large volume solutions, medications and small volume solutions differently based upon site-specific workflow.

Usage Rule: This field is optional for all Pharmacy transactions. When not populated, a default value of "M" is assumed.

Definition: This field contains the telecommunication contact information for the pharmacy. Repetitions may be supplied for various device types or use codes, or multiple instances of the same type or use. This concept also exists as RXO-36 and RXD-34 to support pharmacy contact information in the context of the order, the encoded order and the dispense.